PRESS RELEASE released by Tikomed AB
Viken, Sweden, 4th March 2019
TFS International AB (TFS) appointed CRO representative for TIKOMED's phase 2 study in clinical islet transplantation.
Click here to read the press release.
For further information, please contact Andrew Copestake, EVP Global Business Development and Chief Commercial Officer at TFS International.